New study tests LASMAR score to improve fibroid surgery planning
NCT ID NCT07578246
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether the LASMAR scoring system can predict how well hysteroscopic myomectomy works for women with submucous fibroids. Researchers will check if the score matches surgery time, number of sessions, fluid use, and complications. The goal is to help doctors plan better and reduce risks for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hysteroscopic myomectomy (surgical procedure)
- What this could lead to
- If successful, this could help doctors better predict surgery time, number of sessions needed, and risks for women with uterine fibroids.
- What could go wrong
- This is a small, early-stage observational study with only 88 participants, so results may not apply to everyone. The LASMAR score may not accurately predict outcomes in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAZMAR SCORING , HYSTEROSCOPIC MYOMECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.